nodes	percent_of_prediction	percent_of_DWPC	metapath
Rilpivirine—SLCO1B3—Mycophenolate mofetil—systemic scleroderma	0.152	0.183	CbGbCtD
Rilpivirine—ABCG2—Leflunomide—systemic scleroderma	0.114	0.137	CbGbCtD
Rilpivirine—SLCO1B1—Mycophenolate mofetil—systemic scleroderma	0.0883	0.107	CbGbCtD
Rilpivirine—ABCG2—Mycophenolate mofetil—systemic scleroderma	0.0701	0.0849	CbGbCtD
Rilpivirine—SLCO1B3—Methotrexate—systemic scleroderma	0.0608	0.0736	CbGbCtD
Rilpivirine—CYP1A2—Pentoxifylline—systemic scleroderma	0.0491	0.0594	CbGbCtD
Rilpivirine—CYP1A2—Leflunomide—systemic scleroderma	0.0468	0.0566	CbGbCtD
Rilpivirine—ABCB1—Lisinopril—systemic scleroderma	0.0429	0.0519	CbGbCtD
Rilpivirine—SLCO1B1—Methotrexate—systemic scleroderma	0.0354	0.0428	CbGbCtD
Rilpivirine—ABCB1—Captopril—systemic scleroderma	0.0321	0.0389	CbGbCtD
Rilpivirine—ABCG2—Methotrexate—systemic scleroderma	0.0281	0.034	CbGbCtD
Rilpivirine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0253	0.0306	CbGbCtD
Rilpivirine—CYP2C19—Prednisone—systemic scleroderma	0.0251	0.0303	CbGbCtD
Rilpivirine—ABCB1—Prednisone—systemic scleroderma	0.0202	0.0245	CbGbCtD
Rilpivirine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0152	0.0183	CbGbCtD
Rilpivirine—CYP3A4—Prednisone—systemic scleroderma	0.0121	0.0147	CbGbCtD
Rilpivirine—ABCB1—Methotrexate—systemic scleroderma	0.0101	0.0123	CbGbCtD
Rilpivirine—Cholecystitis—Mycophenolate mofetil—systemic scleroderma	0.00163	0.00942	CcSEcCtD
Rilpivirine—Hepatotoxicity—Leflunomide—systemic scleroderma	0.00161	0.0093	CcSEcCtD
Rilpivirine—Opportunistic infection—Prednisone—systemic scleroderma	0.00158	0.0091	CcSEcCtD
Rilpivirine—Cholelithiasis—Mycophenolate mofetil—systemic scleroderma	0.00151	0.0087	CcSEcCtD
Rilpivirine—Opportunistic infection—Methotrexate—systemic scleroderma	0.00132	0.00761	CcSEcCtD
Rilpivirine—Inflammation—Leflunomide—systemic scleroderma	0.00128	0.00741	CcSEcCtD
Rilpivirine—Creatinine increased—Mycophenolic acid—systemic scleroderma	0.00125	0.0072	CcSEcCtD
Rilpivirine—Abdominal discomfort—Pentoxifylline—systemic scleroderma	0.0012	0.00692	CcSEcCtD
Rilpivirine—Abnormal dreams—Mycophenolic acid—systemic scleroderma	0.00118	0.00677	CcSEcCtD
Rilpivirine—Creatinine increased—Lisinopril—systemic scleroderma	0.00113	0.00648	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Pentoxifylline—systemic scleroderma	0.00106	0.00608	CcSEcCtD
Rilpivirine—Sleep disorder—Leflunomide—systemic scleroderma	0.00105	0.00602	CcSEcCtD
Rilpivirine—Creatinine increased—Mycophenolate mofetil—systemic scleroderma	0.000986	0.00568	CcSEcCtD
Rilpivirine—Renal impairment—Mycophenolic acid—systemic scleroderma	0.000907	0.00523	CcSEcCtD
Rilpivirine—Immune system disorder—Pentoxifylline—systemic scleroderma	0.000905	0.00522	CcSEcCtD
Rilpivirine—Sleep disorder—Lisinopril—systemic scleroderma	0.000898	0.00518	CcSEcCtD
Rilpivirine—Renal failure—Captopril—systemic scleroderma	0.000832	0.00479	CcSEcCtD
Rilpivirine—Renal impairment—Lisinopril—systemic scleroderma	0.000817	0.00471	CcSEcCtD
Rilpivirine—Blood creatinine increased—Mycophenolic acid—systemic scleroderma	0.000809	0.00466	CcSEcCtD
Rilpivirine—Abdominal discomfort—Azathioprine—systemic scleroderma	0.000794	0.00457	CcSEcCtD
Rilpivirine—Immune system disorder—Mometasone—systemic scleroderma	0.000781	0.0045	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Mycophenolic acid—systemic scleroderma	0.000777	0.00448	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Mycophenolic acid—systemic scleroderma	0.000761	0.00439	CcSEcCtD
Rilpivirine—Anxiety—Pentoxifylline—systemic scleroderma	0.00074	0.00427	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—systemic scleroderma	0.000738	0.00425	CcSEcCtD
Rilpivirine—Blood creatinine increased—Lisinopril—systemic scleroderma	0.000728	0.0042	CcSEcCtD
Rilpivirine—Dry mouth—Pentoxifylline—systemic scleroderma	0.000726	0.00419	CcSEcCtD
Rilpivirine—Renal impairment—Mycophenolate mofetil—systemic scleroderma	0.000716	0.00412	CcSEcCtD
Rilpivirine—Infection—Pentoxifylline—systemic scleroderma	0.000707	0.00408	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Azathioprine—systemic scleroderma	0.000698	0.00402	CcSEcCtD
Rilpivirine—Skin disorder—Pentoxifylline—systemic scleroderma	0.000691	0.00399	CcSEcCtD
Rilpivirine—Hepatotoxicity—Methotrexate—systemic scleroderma	0.000688	0.00397	CcSEcCtD
Rilpivirine—Renal failure—Leflunomide—systemic scleroderma	0.000685	0.00395	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Leflunomide—systemic scleroderma	0.000659	0.0038	CcSEcCtD
Rilpivirine—Renal failure—Mycophenolic acid—systemic scleroderma	0.000654	0.00377	CcSEcCtD
Rilpivirine—Insomnia—Pentoxifylline—systemic scleroderma	0.000644	0.00371	CcSEcCtD
Rilpivirine—Blood creatinine increased—Mycophenolate mofetil—systemic scleroderma	0.000638	0.00368	CcSEcCtD
Rilpivirine—Somnolence—Pentoxifylline—systemic scleroderma	0.000633	0.00365	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Mycophenolic acid—systemic scleroderma	0.000629	0.00363	CcSEcCtD
Rilpivirine—Dry mouth—Mometasone—systemic scleroderma	0.000627	0.00361	CcSEcCtD
Rilpivirine—Decreased appetite—Pentoxifylline—systemic scleroderma	0.000619	0.00357	CcSEcCtD
Rilpivirine—Urinary tract disorder—Leflunomide—systemic scleroderma	0.000618	0.00356	CcSEcCtD
Rilpivirine—Urethral disorder—Leflunomide—systemic scleroderma	0.000614	0.00354	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Mycophenolate mofetil—systemic scleroderma	0.000613	0.00353	CcSEcCtD
Rilpivirine—Infection—Mometasone—systemic scleroderma	0.00061	0.00352	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Mycophenolate mofetil—systemic scleroderma	0.000601	0.00346	CcSEcCtD
Rilpivirine—Immune system disorder—Azathioprine—systemic scleroderma	0.000599	0.00345	CcSEcCtD
Rilpivirine—Depression—Lisinopril—systemic scleroderma	0.000597	0.00344	CcSEcCtD
Rilpivirine—Urinary tract disorder—Mycophenolic acid—systemic scleroderma	0.00059	0.0034	CcSEcCtD
Rilpivirine—Renal failure—Lisinopril—systemic scleroderma	0.000589	0.00339	CcSEcCtD
Rilpivirine—Urethral disorder—Mycophenolic acid—systemic scleroderma	0.000585	0.00337	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.000582	0.00335	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Lisinopril—systemic scleroderma	0.000567	0.00327	CcSEcCtD
Rilpivirine—Immune system disorder—Leflunomide—systemic scleroderma	0.000565	0.00326	CcSEcCtD
Rilpivirine—Abdominal pain—Pentoxifylline—systemic scleroderma	0.000563	0.00324	CcSEcCtD
Rilpivirine—Dry mouth—Captopril—systemic scleroderma	0.00055	0.00317	CcSEcCtD
Rilpivirine—Mental disorder—Leflunomide—systemic scleroderma	0.000548	0.00316	CcSEcCtD
Rilpivirine—Inflammation—Methotrexate—systemic scleroderma	0.000548	0.00316	CcSEcCtD
Rilpivirine—Malnutrition—Leflunomide—systemic scleroderma	0.000545	0.00314	CcSEcCtD
Rilpivirine—Decreased appetite—Mometasone—systemic scleroderma	0.000534	0.00308	CcSEcCtD
Rilpivirine—Urinary tract disorder—Lisinopril—systemic scleroderma	0.000531	0.00306	CcSEcCtD
Rilpivirine—Fatigue—Mometasone—systemic scleroderma	0.00053	0.00305	CcSEcCtD
Rilpivirine—Urethral disorder—Lisinopril—systemic scleroderma	0.000527	0.00304	CcSEcCtD
Rilpivirine—Depression—Mycophenolate mofetil—systemic scleroderma	0.000523	0.00302	CcSEcCtD
Rilpivirine—Mental disorder—Mycophenolic acid—systemic scleroderma	0.000523	0.00301	CcSEcCtD
Rilpivirine—Malnutrition—Mycophenolic acid—systemic scleroderma	0.00052	0.003	CcSEcCtD
Rilpivirine—Renal failure—Mycophenolate mofetil—systemic scleroderma	0.000516	0.00297	CcSEcCtD
Rilpivirine—Asthenia—Pentoxifylline—systemic scleroderma	0.000511	0.00294	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Mometasone—systemic scleroderma	0.000502	0.00289	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Mycophenolate mofetil—systemic scleroderma	0.000496	0.00286	CcSEcCtD
Rilpivirine—Insomnia—Captopril—systemic scleroderma	0.000488	0.00281	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.000488	0.00281	CcSEcCtD
Rilpivirine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000487	0.00281	CcSEcCtD
Rilpivirine—Abdominal pain—Mometasone—systemic scleroderma	0.000486	0.0028	CcSEcCtD
Rilpivirine—Somnolence—Captopril—systemic scleroderma	0.00048	0.00276	CcSEcCtD
Rilpivirine—Mental disorder—Lisinopril—systemic scleroderma	0.000471	0.00272	CcSEcCtD
Rilpivirine—Dizziness—Pentoxifylline—systemic scleroderma	0.000471	0.00271	CcSEcCtD
Rilpivirine—Decreased appetite—Captopril—systemic scleroderma	0.000469	0.0027	CcSEcCtD
Rilpivirine—Malnutrition—Lisinopril—systemic scleroderma	0.000468	0.0027	CcSEcCtD
Rilpivirine—Infection—Azathioprine—systemic scleroderma	0.000468	0.0027	CcSEcCtD
Rilpivirine—Urinary tract disorder—Mycophenolate mofetil—systemic scleroderma	0.000465	0.00268	CcSEcCtD
Rilpivirine—Fatigue—Captopril—systemic scleroderma	0.000465	0.00268	CcSEcCtD
Rilpivirine—Anxiety—Leflunomide—systemic scleroderma	0.000462	0.00266	CcSEcCtD
Rilpivirine—Urethral disorder—Mycophenolate mofetil—systemic scleroderma	0.000462	0.00266	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.000461	0.00265	CcSEcCtD
Rilpivirine—Skin disorder—Azathioprine—systemic scleroderma	0.000457	0.00264	CcSEcCtD
Rilpivirine—Dry mouth—Leflunomide—systemic scleroderma	0.000454	0.00261	CcSEcCtD
Rilpivirine—Vomiting—Pentoxifylline—systemic scleroderma	0.000453	0.00261	CcSEcCtD
Rilpivirine—Rash—Pentoxifylline—systemic scleroderma	0.000449	0.00259	CcSEcCtD
Rilpivirine—Dermatitis—Pentoxifylline—systemic scleroderma	0.000448	0.00258	CcSEcCtD
Rilpivirine—Headache—Pentoxifylline—systemic scleroderma	0.000446	0.00257	CcSEcCtD
Rilpivirine—Infection—Leflunomide—systemic scleroderma	0.000442	0.00255	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Captopril—systemic scleroderma	0.000441	0.00254	CcSEcCtD
Rilpivirine—Anxiety—Mycophenolic acid—systemic scleroderma	0.000441	0.00254	CcSEcCtD
Rilpivirine—Asthenia—Mometasone—systemic scleroderma	0.000441	0.00254	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000439	0.00253	CcSEcCtD
Rilpivirine—Nervous system disorder—Leflunomide—systemic scleroderma	0.000436	0.00251	CcSEcCtD
Rilpivirine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000433	0.00249	CcSEcCtD
Rilpivirine—Skin disorder—Leflunomide—systemic scleroderma	0.000432	0.00249	CcSEcCtD
Rilpivirine—Abdominal pain—Captopril—systemic scleroderma	0.000427	0.00246	CcSEcCtD
Rilpivirine—Nausea—Pentoxifylline—systemic scleroderma	0.000423	0.00244	CcSEcCtD
Rilpivirine—Infection—Mycophenolic acid—systemic scleroderma	0.000421	0.00243	CcSEcCtD
Rilpivirine—Diarrhoea—Mometasone—systemic scleroderma	0.00042	0.00242	CcSEcCtD
Rilpivirine—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000416	0.0024	CcSEcCtD
Rilpivirine—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000413	0.00238	CcSEcCtD
Rilpivirine—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000412	0.00237	CcSEcCtD
Rilpivirine—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.00041	0.00236	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.000407	0.00235	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000407	0.00234	CcSEcCtD
Rilpivirine—Insomnia—Leflunomide—systemic scleroderma	0.000402	0.00232	CcSEcCtD
Rilpivirine—Anxiety—Lisinopril—systemic scleroderma	0.000397	0.00229	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000396	0.00228	CcSEcCtD
Rilpivirine—Vomiting—Mometasone—systemic scleroderma	0.000391	0.00225	CcSEcCtD
Rilpivirine—Dry mouth—Lisinopril—systemic scleroderma	0.00039	0.00225	CcSEcCtD
Rilpivirine—Rash—Mometasone—systemic scleroderma	0.000387	0.00223	CcSEcCtD
Rilpivirine—Asthenia—Captopril—systemic scleroderma	0.000387	0.00223	CcSEcCtD
Rilpivirine—Dermatitis—Mometasone—systemic scleroderma	0.000387	0.00223	CcSEcCtD
Rilpivirine—Decreased appetite—Leflunomide—systemic scleroderma	0.000387	0.00223	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000385	0.00222	CcSEcCtD
Rilpivirine—Headache—Mometasone—systemic scleroderma	0.000385	0.00222	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000384	0.00221	CcSEcCtD
Rilpivirine—Insomnia—Mycophenolic acid—systemic scleroderma	0.000384	0.00221	CcSEcCtD
Rilpivirine—Fatigue—Leflunomide—systemic scleroderma	0.000383	0.00221	CcSEcCtD
Rilpivirine—Infection—Lisinopril—systemic scleroderma	0.00038	0.00219	CcSEcCtD
Rilpivirine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000377	0.00217	CcSEcCtD
Rilpivirine—Abdominal pain—Azathioprine—systemic scleroderma	0.000372	0.00215	CcSEcCtD
Rilpivirine—Skin disorder—Lisinopril—systemic scleroderma	0.000371	0.00214	CcSEcCtD
Rilpivirine—Diarrhoea—Captopril—systemic scleroderma	0.000369	0.00213	CcSEcCtD
Rilpivirine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000369	0.00213	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000366	0.00211	CcSEcCtD
Rilpivirine—Fatigue—Mycophenolic acid—systemic scleroderma	0.000366	0.00211	CcSEcCtD
Rilpivirine—Nausea—Mometasone—systemic scleroderma	0.000365	0.0021	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000364	0.0021	CcSEcCtD
Rilpivirine—Dizziness—Captopril—systemic scleroderma	0.000357	0.00206	CcSEcCtD
Rilpivirine—Depression—Prednisone—systemic scleroderma	0.000355	0.00204	CcSEcCtD
Rilpivirine—Abdominal pain—Leflunomide—systemic scleroderma	0.000352	0.00203	CcSEcCtD
Rilpivirine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000348	0.00201	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000347	0.002	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000347	0.002	CcSEcCtD
Rilpivirine—Insomnia—Lisinopril—systemic scleroderma	0.000346	0.00199	CcSEcCtD
Rilpivirine—Vomiting—Captopril—systemic scleroderma	0.000343	0.00198	CcSEcCtD
Rilpivirine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000342	0.00197	CcSEcCtD
Rilpivirine—Rash—Captopril—systemic scleroderma	0.00034	0.00196	CcSEcCtD
Rilpivirine—Dermatitis—Captopril—systemic scleroderma	0.00034	0.00196	CcSEcCtD
Rilpivirine—Somnolence—Lisinopril—systemic scleroderma	0.00034	0.00196	CcSEcCtD
Rilpivirine—Headache—Captopril—systemic scleroderma	0.000338	0.00195	CcSEcCtD
Rilpivirine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000335	0.00193	CcSEcCtD
Rilpivirine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000333	0.00192	CcSEcCtD
Rilpivirine—Decreased appetite—Lisinopril—systemic scleroderma	0.000332	0.00191	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00033	0.0019	CcSEcCtD
Rilpivirine—Fatigue—Lisinopril—systemic scleroderma	0.000329	0.0019	CcSEcCtD
Rilpivirine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000328	0.00189	CcSEcCtD
Rilpivirine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000325	0.00187	CcSEcCtD
Rilpivirine—Diarrhoea—Azathioprine—systemic scleroderma	0.000322	0.00186	CcSEcCtD
Rilpivirine—Nausea—Captopril—systemic scleroderma	0.00032	0.00185	CcSEcCtD
Rilpivirine—Abdominal discomfort—Methotrexate—systemic scleroderma	0.00032	0.00184	CcSEcCtD
Rilpivirine—Asthenia—Leflunomide—systemic scleroderma	0.000319	0.00184	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000312	0.0018	CcSEcCtD
Rilpivirine—Dizziness—Azathioprine—systemic scleroderma	0.000311	0.00179	CcSEcCtD
Rilpivirine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000304	0.00175	CcSEcCtD
Rilpivirine—Diarrhoea—Leflunomide—systemic scleroderma	0.000304	0.00175	CcSEcCtD
Rilpivirine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000303	0.00175	CcSEcCtD
Rilpivirine—Abdominal pain—Lisinopril—systemic scleroderma	0.000302	0.00174	CcSEcCtD
Rilpivirine—Vomiting—Azathioprine—systemic scleroderma	0.000299	0.00173	CcSEcCtD
Rilpivirine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000298	0.00172	CcSEcCtD
Rilpivirine—Rash—Azathioprine—systemic scleroderma	0.000297	0.00171	CcSEcCtD
Rilpivirine—Dermatitis—Azathioprine—systemic scleroderma	0.000297	0.00171	CcSEcCtD
Rilpivirine—Depression—Methotrexate—systemic scleroderma	0.000296	0.00171	CcSEcCtD
Rilpivirine—Headache—Azathioprine—systemic scleroderma	0.000295	0.0017	CcSEcCtD
Rilpivirine—Dizziness—Leflunomide—systemic scleroderma	0.000294	0.00169	CcSEcCtD
Rilpivirine—Renal failure—Methotrexate—systemic scleroderma	0.000292	0.00168	CcSEcCtD
Rilpivirine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000291	0.00168	CcSEcCtD
Rilpivirine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00029	0.00167	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000289	0.00167	CcSEcCtD
Rilpivirine—Immune system disorder—Prednisone—systemic scleroderma	0.000288	0.00166	CcSEcCtD
Rilpivirine—Vomiting—Leflunomide—systemic scleroderma	0.000283	0.00163	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000281	0.00162	CcSEcCtD
Rilpivirine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000281	0.00162	CcSEcCtD
Rilpivirine—Rash—Leflunomide—systemic scleroderma	0.00028	0.00162	CcSEcCtD
Rilpivirine—Dermatitis—Leflunomide—systemic scleroderma	0.00028	0.00161	CcSEcCtD
Rilpivirine—Mental disorder—Prednisone—systemic scleroderma	0.00028	0.00161	CcSEcCtD
Rilpivirine—Nausea—Azathioprine—systemic scleroderma	0.00028	0.00161	CcSEcCtD
Rilpivirine—Headache—Leflunomide—systemic scleroderma	0.000279	0.00161	CcSEcCtD
Rilpivirine—Malnutrition—Prednisone—systemic scleroderma	0.000278	0.0016	CcSEcCtD
Rilpivirine—Asthenia—Lisinopril—systemic scleroderma	0.000274	0.00158	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000274	0.00158	CcSEcCtD
Rilpivirine—Vomiting—Mycophenolic acid—systemic scleroderma	0.00027	0.00155	CcSEcCtD
Rilpivirine—Rash—Mycophenolic acid—systemic scleroderma	0.000267	0.00154	CcSEcCtD
Rilpivirine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000267	0.00154	CcSEcCtD
Rilpivirine—Headache—Mycophenolic acid—systemic scleroderma	0.000266	0.00153	CcSEcCtD
Rilpivirine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000265	0.00153	CcSEcCtD
Rilpivirine—Nausea—Leflunomide—systemic scleroderma	0.000264	0.00152	CcSEcCtD
Rilpivirine—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000264	0.00152	CcSEcCtD
Rilpivirine—Urethral disorder—Methotrexate—systemic scleroderma	0.000262	0.00151	CcSEcCtD
Rilpivirine—Diarrhoea—Lisinopril—systemic scleroderma	0.000261	0.00151	CcSEcCtD
Rilpivirine—Dizziness—Lisinopril—systemic scleroderma	0.000253	0.00146	CcSEcCtD
Rilpivirine—Nausea—Mycophenolic acid—systemic scleroderma	0.000252	0.00145	CcSEcCtD
Rilpivirine—Vomiting—Lisinopril—systemic scleroderma	0.000243	0.0014	CcSEcCtD
Rilpivirine—Immune system disorder—Methotrexate—systemic scleroderma	0.000241	0.00139	CcSEcCtD
Rilpivirine—Rash—Lisinopril—systemic scleroderma	0.000241	0.00139	CcSEcCtD
Rilpivirine—Dermatitis—Lisinopril—systemic scleroderma	0.000241	0.00139	CcSEcCtD
Rilpivirine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00024	0.00138	CcSEcCtD
Rilpivirine—Headache—Lisinopril—systemic scleroderma	0.000239	0.00138	CcSEcCtD
Rilpivirine—Anxiety—Prednisone—systemic scleroderma	0.000236	0.00136	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000235	0.00135	CcSEcCtD
Rilpivirine—Mental disorder—Methotrexate—systemic scleroderma	0.000234	0.00135	CcSEcCtD
Rilpivirine—Malnutrition—Methotrexate—systemic scleroderma	0.000232	0.00134	CcSEcCtD
Rilpivirine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000229	0.00132	CcSEcCtD
Rilpivirine—Nausea—Lisinopril—systemic scleroderma	0.000227	0.00131	CcSEcCtD
Rilpivirine—Infection—Prednisone—systemic scleroderma	0.000225	0.0013	CcSEcCtD
Rilpivirine—Nervous system disorder—Prednisone—systemic scleroderma	0.000223	0.00128	CcSEcCtD
Rilpivirine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000221	0.00128	CcSEcCtD
Rilpivirine—Skin disorder—Prednisone—systemic scleroderma	0.00022	0.00127	CcSEcCtD
Rilpivirine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000213	0.00123	CcSEcCtD
Rilpivirine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000211	0.00122	CcSEcCtD
Rilpivirine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000211	0.00122	CcSEcCtD
Rilpivirine—Headache—Mycophenolate mofetil—systemic scleroderma	0.00021	0.00121	CcSEcCtD
Rilpivirine—Insomnia—Prednisone—systemic scleroderma	0.000205	0.00118	CcSEcCtD
Rilpivirine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000199	0.00115	CcSEcCtD
Rilpivirine—Decreased appetite—Prednisone—systemic scleroderma	0.000197	0.00114	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000196	0.00113	CcSEcCtD
Rilpivirine—Fatigue—Prednisone—systemic scleroderma	0.000196	0.00113	CcSEcCtD
Rilpivirine—Infection—Methotrexate—systemic scleroderma	0.000188	0.00109	CcSEcCtD
Rilpivirine—Nervous system disorder—Methotrexate—systemic scleroderma	0.000186	0.00107	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000186	0.00107	CcSEcCtD
Rilpivirine—Skin disorder—Methotrexate—systemic scleroderma	0.000184	0.00106	CcSEcCtD
Rilpivirine—Abdominal pain—Prednisone—systemic scleroderma	0.000179	0.00103	CcSEcCtD
Rilpivirine—Insomnia—Methotrexate—systemic scleroderma	0.000172	0.000989	CcSEcCtD
Rilpivirine—Somnolence—Methotrexate—systemic scleroderma	0.000169	0.000972	CcSEcCtD
Rilpivirine—Decreased appetite—Methotrexate—systemic scleroderma	0.000165	0.00095	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000164	0.000944	CcSEcCtD
Rilpivirine—Fatigue—Methotrexate—systemic scleroderma	0.000164	0.000942	CcSEcCtD
Rilpivirine—Asthenia—Prednisone—systemic scleroderma	0.000163	0.000938	CcSEcCtD
Rilpivirine—Diarrhoea—Prednisone—systemic scleroderma	0.000155	0.000895	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000155	0.000894	CcSEcCtD
Rilpivirine—Dizziness—Prednisone—systemic scleroderma	0.00015	0.000865	CcSEcCtD
Rilpivirine—Abdominal pain—Methotrexate—systemic scleroderma	0.00015	0.000864	CcSEcCtD
Rilpivirine—Vomiting—Prednisone—systemic scleroderma	0.000144	0.000832	CcSEcCtD
Rilpivirine—Rash—Prednisone—systemic scleroderma	0.000143	0.000825	CcSEcCtD
Rilpivirine—Dermatitis—Prednisone—systemic scleroderma	0.000143	0.000824	CcSEcCtD
Rilpivirine—Headache—Prednisone—systemic scleroderma	0.000142	0.000819	CcSEcCtD
Rilpivirine—Asthenia—Methotrexate—systemic scleroderma	0.000136	0.000784	CcSEcCtD
Rilpivirine—Nausea—Prednisone—systemic scleroderma	0.000135	0.000777	CcSEcCtD
Rilpivirine—Diarrhoea—Methotrexate—systemic scleroderma	0.00013	0.000748	CcSEcCtD
Rilpivirine—Dizziness—Methotrexate—systemic scleroderma	0.000125	0.000723	CcSEcCtD
Rilpivirine—Vomiting—Methotrexate—systemic scleroderma	0.000121	0.000695	CcSEcCtD
Rilpivirine—Rash—Methotrexate—systemic scleroderma	0.00012	0.000689	CcSEcCtD
Rilpivirine—Dermatitis—Methotrexate—systemic scleroderma	0.000119	0.000689	CcSEcCtD
Rilpivirine—Headache—Methotrexate—systemic scleroderma	0.000119	0.000685	CcSEcCtD
Rilpivirine—Nausea—Methotrexate—systemic scleroderma	0.000113	0.000649	CcSEcCtD
